Diagnostic challenge of glucagonoma: Case report and literature review

Endocrine Practice

Volumn 12, Issue 4, 2006, Pages 422-426

  Cruz Bautista, Ivette ^a   Lerman, Israel ^a   Perez Enriquez, Bernardo ^a   Padilla, Lorenzo S ^a   Torres, César L ^a   Lopez, Antonio ^a   Cabrera, Tatiana ^a   Mehta, Roopa P ^a   Gómez Pérez, Francisco J ^a   Rull, Juan A ^a   Orozco Topete, Rocio ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; ERYTHEMA; GLOSSITIS; GLUCAGON BLOOD LEVEL; GLUCAGONOMA; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; MALE; PANCREAS RESECTION; RASH; SKIN MANIFESTATION; STOMATITIS; BLOOD FLOW; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; HYPERPIGMENTATION; MIDDLE AGED; PANCREAS TUMOR; ULTRASTRUCTURE; WOUND HEALING;

ERYTHEMA; GLUCAGONOMA; HUMANS; HYPERPIGMENTATION; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; REGIONAL BLOOD FLOW; TOMOGRAPHY, X-RAY COMPUTED; WOUND HEALING;

EID: 33750099553     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.12.4.422     Document Type: Article

References (23)

1. Gumbs AA, Parisi V, Sargenti M, Bassi C. Migratory necrolytic dermatitis presenting after cephalosporin administration in a patient with a pancreatic head mass. Dig Surg. 2004;21:161-163.
2. Mallinson CN, Bloom SR, Warin AP, Salmon PR, Cox B. A glucagonoma syndrome. Lancet. 1974;2:1-5.
3. Chao SC, Lee JY. Brittle nails and dyspareunia as first clues to recurrences of malignant glucagonoma. Br J Dermatol. 2002;146:1071-1074.
4. Pujol RM, Wang CY, el-Azhary RA, Su WP, Gibson LE, Schroeter AL. Necrolytic migratory erythema: clinicopathologic study of 13 cases. Int J Dermatol. 2004;43:12-18.
5. Johnson SM, Smoller BR, Lamps LW, Horn TD. Necrolytic migratory erythema as the only presenting sign of a glucagonoma. J Am Acad Dermatol. 2003;49:325-328.
6. Alkemade JA, van Tongeren JH, van Haelst UJ, Smals A, Steijlen PM, van de Kerkhof PC. Delayed diagnosis of glucagonoma syndrome. Clin Exp Dermatol. 1999;24: 455-457.
7. Adam DN, Cohen PD, Ghazarian D. Necrolytic migratory erythema: case report and clinical review. J Cutan Med Surg. 2003;7:333-338.
8. Smith AP, Doolas A, Staren ED. Rapid resolution of necrolytic migratory erythema after glucagonorna resection. J Surg Oncol. 1996;61:306-309.
9. Hivnor CM, Yan AC, Junkins-Hopkins JM, Honig PJ. Necrolytic acral erythema: response to combination therapy with interferon and ribavirin. J Am Acad Dermatol. 2004;50(5 Suppl):S121-S124.
10. Blackford S, Wright S, Roberts DL. Necrolytic migratory erythema without glucagonoma: the role of dietary essential fatty acids. Br J Dermatol. 1991;125:460-462.
11. Becker SW, Kahn D, Rothman S. Cutaneous manifestations of internal malignant tumors. Arch Dermatol Syphilol. 1942;45:1069-1080.
12. Du Jardin P, Cools P, Van der Stighelen Y. Necrolytic migratory erythema: first symptom of a glucagonoma; a case report. Acta Chir Belg. 2004;104:468-470.
13. Remes-Troche JM, Garcia-de-Acevedo B, Zuniga-Varga J, Avila-Funes A, Orozco-Topete R. Necrolytic migratory erythema: a cutaneous clue to glucagonoma syndrome. J Eur Acad Dermatol Venereol. 2004;18:591-595.
14. Zhang M, Xu X, Shen Y, Hu ZH, Wu LM, Zheng SS. Clinical experience in diagnosis and treatment of glucagonoma syndrome. Hepatobiliary Pancreat Dis Int. 2004;3:473-475.
15. Mullans EA, Cohen PR. Iatrogenic necrolytic migratory erythema: a case report and review of nonglucagonoma-associated necrolytic migratory erythema. J Am Acad Dermatol. 1998;38(5 pt 2):866-873.
16. Tierney EP, Badger J. Etiology and pathogenesis of necrolytic migratory erythema: review of the literature. MedGenMed. 2004;6:4.
17. Johnson DS, Coel MN, Bornemann M. Current imaging and possible therapeutic management of glucagonoma tumors: a case report. Clin Nucl Med. 2000;25:120-122.
18. Yasuda S, Shohtsu A, Tomioka K. F-18 fluorodeoxyglucose positron emission tomography imaging in ectopic nonfunctioning glucagonoma. Clin Nucl Med. 1998;23: 474-475.
19. Vázquez Muñoz E, Franco Lopez A, Pérez-Villacastin B, Pallardo Sánchez LF. Imaging advances in the diagnosis of neuroendocrine tumors [article in Spanish]. An Med Interna. 2004; 21:491-494.
20. Aggarwal A, Brainard J, Brotman DJ. Spinal metastasis as the initial manifestation of a nonsecretory glucagonoma. South Med J. 2003;96:190-193.
21. Alexander EK, Robinson M, Staniec M, Dluhy RG. Peripheral amino acid and fatty acid infusion for the treatment of necrolytic migratory erythema in the glucagonoma syndrome. Clin Endocrinol (Oxf). 2002;57:827-831.
22. Arnold R, Wied M, Behr TH. Somatostatin analogues in the treatment of endocrine tumors of the gastrointestinal tract [erraturn in Expert Opin Pharmacother. 2002;3: 1029]. Expert Opin Pharmacother. 2002;3:643-656.
23. McEntee GP, Nagorney DM, Kvols LK, Moertel CG, Grant CS. Cytoreductive hepatic surgery for neuroendocrine, tumors. Surgery. 1990;108:1091-1096.